Co-infection with human immunodeficiency virus and tuberculosis.
Elston
James W T
JW
Department of Infection and Tropical Medicine, Hull and East Yorkshire Hospitals Trust, United Kingdom.
Thaker
Hiten K B
HK
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use; D023801:Directly Observed Therapy; D004347:Drug Interactions; D024901:Drug Resistance, Multiple, Bacterial; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D055502:Secondary Prevention; D014376:Tuberculosis / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy
D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents; D001500:BCG Vaccine